The DOI matches its Crossref record.
Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans
Abstract
Hyperhomocyst(e)inaemia is associated with endothelial dysfunction in animals and humans. Mechanisms responsible for endothelial dysfunction in hyperhomocyst(e)inaemia are poorly understood, but may involve impaired bioavailability of endothelium-derived nitric oxide (NO). We hypothesized that acute elevation of homocyst(e)ine by oral methionine loading may stimulate the formation of asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, due to a transmethylation reaction during the formation of homocyst(e)ine from methionine. We studied nine healthy human subjects (five males, four females) aged 29±2 years. Flow-mediated vasodilation (FMD) in the brachial artery (endothelium-dependent) and vasodilation induced by nitroglycerine (endothelium-independent) were measured with high-resolution ultrasound before and 8 h after oral methionine (100 mg/kg in cranberry juice) or placebo (cranberry juice), on separate days and in random order. Plasma homocyst(e)ine and ADMA concentrations were measured by specific HPLC methods. After a methionine bolus, elevation of homocyst(e)ine (28.4±3.5 µmol/l) was associated with an increased plasma concentration of ADMA (2.03±0.18 µmol/l) and reduced FMD (1.54±0.92%). Placebo had no effect on these parameters. There was a significant inverse linear relationship between ADMA concentration and FMD (r =-0.49; P < 0.05), which was stronger than the relationship between the homocyst(e)ine concentration and FMD (r =-0.36; not significant). We conclude that acute elevation of the homocyst(e)ine concentration impairs vascular endothelial function by a mechanism in which an elevated concentration of ADMA may be involved. This finding may have importance for understanding the mechanism(s) leading to homocyst(e)ine-associated vascular disease, and its potential treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease
Austin, R. C., Lentz, S. R., & Werstuck, G. H. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401451 · Cited by 414
Self-citationMechanisms of homocysteine‐induced atherothrombosis
LENTZ, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01364.x · Cited by 363
Self-citationEndothelial dysfunction and cardiovascular disease
Jay Widmer, R., & Lerman, A. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.43 · Cited by 356
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
Metadata
- Authors
- BÖGER, R. H., LENTZ, S. R., BODE-BÖGER, S. M., KNAPP, H. R., & HAYNES, W. G.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2001-01-02
- Volume
- 100
- Issue
- 2
- Pages
- 161-167
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2033228105
- Cited by
- 204
- References
- 0
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. https://app.cochat.ai/papers/10.1042/cs1000161
- The paper
- BÖGER, R. H., LENTZ, S. R., BODE-BÖGER, S. M., KNAPP, H. R., & HAYNES, W. G. (2001). Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clinical Science. https://doi.org/10.1042/cs1000161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.